• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYSMEX CORPORATION, I SQUARE CS-2500; AUTOMATED BLOOD COAGULATION ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYSMEX CORPORATION, I SQUARE CS-2500; AUTOMATED BLOOD COAGULATION ANALYZER Back to Search Results
Model Number CS-2500
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/21/2021
Event Type  Injury  
Manufacturer Narrative
The sysmex cs-2500 instructions for use (ifu), chapter 8 - troubleshooting, section 8.5.2 - analysis data errors, states for error code 0008.0128.002: [early reaction error: start angle 1], "an abnormal reaction was detected at the initial stage of the aptt coagulation reaction.Check the coagulation curve and follow the judgment criteria for your institution.Alternatively, check the volumes of sample and reagent, then repeat the test." all analyses generated results with asterisks [*].Chapter 2 - principles of operation, section 2.9.2 - checking the analysis result list, provides overview and interpretation of the analysis results.A numerical result with [*] indicates a low-reliability analysis result and a result of [****.*] indicates the analysis result could not be obtained due to errors and other problems.It is the responsibility of the operator to verify results prior to reporting.The laboratory manager reported the operator erroneously interpreted the flagged analyses results and failed to follow laboratory policy.Laboratory policy is to recollect the sample and send out for testing using an alternate methodology.No analyzer deficiency was identified.
 
Event Description
Multiple samples from the same patient were analyzed for activated partial thromboplastin time (aptt) and generated results with asterisks.The operator reviewed the coagulation curve and reported a numerical value for the aptt result.The operator reported a falsely decreased aptt result on an analysis that generated error code 0008.0128.002: [early reaction error: start angle 1].The patient was receiving intravenous heparin treatment and the treatment continued based on the erroneous aptt result.There was no harm to the patient reported due to the prolonged heparin treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CS-2500
Type of Device
AUTOMATED BLOOD COAGULATION ANALYZER
Manufacturer (Section D)
SYSMEX CORPORATION, I SQUARE
262-11 mizuashi
noguchi-cho
kakogawa-city, hyogo 675-0 019
JA  675-0019
Manufacturer (Section G)
SYSMEX CORPORATION, I SQUARE
262-11 mizuashi
noguchi-cho
kakogawa-city, hyogo 675-0 019
JA   675-0019
Manufacturer Contact
nancy gould
577 aptakisic rd
lincolnshire, IL 60069
2245439678
MDR Report Key11631167
MDR Text Key260512841
Report Number1000515253-2021-00008
Device Sequence Number1
Product Code JPA
UDI-Device Identifier04987562433735
UDI-Public(01)04987562433735(11)161110
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K172286
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCS-2500
Device Catalogue NumberBV981798
Was Device Available for Evaluation? Yes
Date Manufacturer Received03/30/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/01/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age63 YR
-
-